Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans - PubMed (original) (raw)

Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans

Isil Fidan et al. Mycoses. 2009 Jan.

Abstract

Saccharomyces boulardii (S. boulardii) is a probiotic and used in the prevention or treatment of diarrhoea. Saccharomyces boulardii has many mechanisms to protect the host against diarrhoeal pathogens. It might modulate the immune system. In this study, the influence of S. boulardii on the secretion of cytokines from intraepithelial lymphocytes (IELs) infected with Escherichia coli (E. coli) and Candida albicans (C. albicans) was investigated in vitro. Cytokine levels were determined by enzyme-linked immunosorbent assay. The secretion of proinflammatory cytokines such as interleukin (IL)-1beta was decreased in the infected IELs incubated with S. boulardii, but different from it, anti-inflammatory cytokine levels such as IL-4 and IL-10, however, were found to be higher. These findings demonstrated that S. boulardii may have protective effects against diarrhoeal pathogens by reducing the proinflammatory response.

PubMed Disclaimer

Similar articles

• The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.
  Murzyn A, Krasowska A, Augustyniak D, Majkowska-Skrobek G, Łukaszewicz M, Dziadkowiec D. Murzyn A, et al. FEMS Microbiol Lett. 2010 Sep 1;310(1):17-23. doi: 10.1111/j.1574-6968.2010.02037.x. Epub 2010 Jun 16. FEMS Microbiol Lett. 2010. PMID: 20629753
• The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation.
  Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D. Krasowska A, et al. FEMS Yeast Res. 2009 Dec;9(8):1312-21. doi: 10.1111/j.1567-1364.2009.00559.x. Epub 2009 Aug 5. FEMS Yeast Res. 2009. PMID: 19732158
• Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
  Justino PF, Melo LF, Nogueira AF, Costa JV, Silva LM, Santos CM, Mendes WO, Costa MR, Franco AX, Lima AA, Ribeiro RA, Souza MH, Soares PM. Justino PF, et al. Br J Nutr. 2014 May;111(9):1611-21. doi: 10.1017/S0007114513004248. Epub 2014 Feb 6. Br J Nutr. 2014. PMID: 24503021
• Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?
  Buts JP, De Keyser N. Buts JP, et al. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):532-3. doi: 10.1097/MPG.0b013e3181e23271. J Pediatr Gastroenterol Nutr. 2010. PMID: 20706146 Review.
• Celiac disease pathogenesis: the proinflammatory cytokine network.
  Garrote JA, Gómez-González E, Bernardo D, Arranz E, Chirdo F. Garrote JA, et al. J Pediatr Gastroenterol Nutr. 2008 Aug;47 Suppl 1:S27-32. doi: 10.1097/MPG.0b013e3181818fb9. J Pediatr Gastroenterol Nutr. 2008. PMID: 18667914 Review.

Cited by

• The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children.
  Bin Z, Ya-Zheng X, Zhao-Hui D, Bo C, Li-Rong J, Vandenplas Y. Bin Z, et al. Pediatr Gastroenterol Hepatol Nutr. 2015 Mar;18(1):17-22. doi: 10.5223/pghn.2015.18.1.17. Epub 2015 Mar 30. Pediatr Gastroenterol Hepatol Nutr. 2015. PMID: 25866729 Free PMC article.
• Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial.
  Dolatkhah N, Jafari A, Eslamian F, Toopchizadeh V, Saleh P, Hashemian M. Dolatkhah N, et al. Eur J Nutr. 2024 Sep;63(6):2291-2305. doi: 10.1007/s00394-024-03428-5. Epub 2024 May 18. Eur J Nutr. 2024. PMID: 38761281 Clinical Trial.
• Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
  García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, Carranza-Muleiro RA, Jara LJ, Vera-Lastra O, Montes-Cortes DH, Medina G, Cruz-Domínguez MP. García-Collinot G, et al. Dig Dis Sci. 2020 Apr;65(4):1134-1143. doi: 10.1007/s10620-019-05830-0. Epub 2019 Sep 23. Dig Dis Sci. 2020. PMID: 31549334 Clinical Trial.
• Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions.
  Jawhara S, Habib K, Maggiotto F, Pignede G, Vandekerckove P, Maes E, Dubuquoy L, Fontaine T, Guerardel Y, Poulain D. Jawhara S, et al. PLoS One. 2012;7(7):e40648. doi: 10.1371/journal.pone.0040648. Epub 2012 Jul 27. PLoS One. 2012. PMID: 22848391 Free PMC article.
• The preventive effects of Saccharomyces boulardii against oxidative stress induced by lipopolysaccharide in rat brain.
  Babaei F, Navidi-Moghaddam A, Naderi A, Ghafghazi S, Mirzababaei M, Dargahi L, Mohammadi G, Nassiri-Asl M. Babaei F, et al. Heliyon. 2024 Apr 26;10(9):e30426. doi: 10.1016/j.heliyon.2024.e30426. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720760 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley